Icon
+91 94997 68112
Login Register

Ninlaro - (2.3, 3, 4 mg; Capsule, Oral)

Ixazomib Citrate Millenium Pharma
2.3, 3, 4 mg; Capsule, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
None None
NINLARO is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
Yes
*** *********** **** ** *** **, **** *** ****** ** ***. *** ****** ***** * **** ** ** ******* '***, '***, '*** *** *** *********. ********* ** ********** (******) *** ******, ******** ****** (*******) ** ******** ******* ******* ** *** ****. *** ******** ****** (*******) *** ********** ***** ** ****** ** *** ***, **** ** *** *** **** **. ** ** *** ****** ****** ****** ****. ( *****://***.***.***/********/*****/****/*******/******************/***************.*** ) *** **** ** **** ****** *** **** ******** **** **, ******** ****, ** *** *** **** **. ** ** *** ****** ****** ****** ****. ( *****://***.******.***/******/**********/******/*********/******/***-*******/**-*_****_**_**_**.*** ) ********** ******* **** *** ****** *** *** ****** ***'* ****** *** ******* ***** *** ********** ** ******* '***, '*** *** '*** (*.* ***** *** ****)
Ninlaro Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9
*** ****** ******* ******* ******* ******* ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
*** ****** *** \ ********* *** **, **** ******* **** ***** *** **** (***** ******)
  1. *** **, **** : *** ****** ******** ********** ***** **'* **** ** ****** ** ******* '***, '*** *** '***.
  2. *** **, **** : ********** ***** * **** ******* *** ****** ** ******* '***, '*** *** '***.
  3. *** **, **** : ********** ******* **** *** ****** *** *** ****** ***'* ****** *** ******* ***** *** ********** ** ******* '***, '*** *** '***

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.